New Treatments for ED After Prostatectomy

The treatment landscape for erectile dysfunction after prostatectomy has expanded well beyond the familiar pill-based approach. While PDE5 inhibitors remain the standard first step, a growing toolkit now includes low-intensity shockwave therapy, stem cell injections, platelet-rich plasma, nerve grafting procedures, and refined approaches to pelvic floor training. Most of these are still working their way through clinical trials, but the direction of the research is clear: recovery strategies are becoming more targeted and more layered than they were even a decade ago.

Why Prostatectomy Causes Erectile Dysfunction in the First Place

The cavernous nerves, which run along both sides of the prostate, are the main signaling pathway that triggers an erection. Even in “nerve-sparing” surgery, where the surgeon tries to preserve these nerves, they can be stretched, bruised, or partially damaged. That injury sets off a chain of events inside the penile tissue itself. Without regular nerve signals, smooth muscle cells in the penis begin to be replaced by fibrous scar tissue. Animal research has shown that molecular signaling pathways involving compounds like sphingosine-1-phosphate ramp up after nerve injury, driving this fibrosis and smooth muscle loss.¹ The practical result is that the longer the penis goes without adequate blood flow and nerve stimulation, the harder recovery becomes. This is why researchers talk about “penile rehabilitation” as a time-sensitive process rather than something you can delay indefinitely.

PDE5 Inhibitors and the Rehabilitation Debate

Drugs like sildenafil, tadalafil, and vardenafil are still the first treatment most men receive after surgery. A meta-analysis pooling data from multiple trials after nerve-sparing prostatectomy found that these medications produced meaningful improvements in erectile function scores and roughly doubled the odds of recovering erections compared to placebo.² That sounds encouraging, but the picture gets more complicated when you ask how to use them.

For years, the dominant idea was that taking a PDE5 inhibitor every night, rather than only before sex, would keep oxygen-rich blood flowing to the penile tissue and slow down the fibrosis process. The evidence has not strongly supported that theory. A randomized trial comparing nightly sildenafil to on-demand use after nerve-sparing surgery found no significant difference in erectile function recovery at any time point, whether measured by standardized scores, the percentage of men regaining firm erections, or the frequency of attempted intercourse.³ A separate trial using vardenafil reached a similar conclusion: while on-demand dosing looked slightly better during the active treatment period, the advantage disappeared after a washout period when neither group was taking the drug.⁴

A meta-analysis that combined four trials with over 800 patients confirmed this pattern: regular nightly use did not produce a significantly higher proportion of men reaching strong erectile function scores compared to on-demand use.⁵ This matters practically because nightly dosing costs more, involves daily side effects like headaches and flushing, and can become discouraging when taken without an immediate sexual purpose. For most men, on-demand use appears to be the more reasonable starting approach.

Low-Intensity Shockwave Therapy

Low-intensity extracorporeal shockwave therapy, often abbreviated Li-ESWT, uses acoustic waves applied to the penile tissue to stimulate new blood vessel growth, encourage nerve fiber regeneration, and improve the function of the cells lining blood vessels. In animal models mimicking post-prostatectomy nerve damage, shockwave treatment reduced the fibrosis in penile tissue, preserved smooth muscle, and triggered the production of factors associated with new blood vessel formation.⁶ Clinical studies in men who had bilateral nerve-sparing surgery have shown promising early results, though large randomized trials are still needed to confirm how well the benefits hold up over years and across different patient populations.

Shockwave therapy is appealing partly because it is noninvasive, performed in an office setting over several sessions, and has minimal side effects. It is also one of the few treatments that aims to address the underlying tissue damage rather than working around it. The catch is that availability varies widely, and many clinics offering it are doing so outside the context of rigorous clinical protocols. If you are considering this, look for a provider affiliated with an academic medical center or a clinical trial.

Stem Cells and Platelet-Rich Plasma

The idea behind stem cell therapy for post-prostatectomy ED is straightforward in concept, even if the science is complex: inject cells into the penile tissue that can repair damaged nerves and blood vessels from the inside. Animal studies using various cell types have been encouraging. One study in rats with bilateral cavernous nerve injury found that injecting endothelial progenitor cells or smooth muscle progenitor cells into the penile tissue significantly restored erectile function, preserved smooth muscle content, and increased the expression of markers associated with healthy blood vessel lining.⁷

In humans, early-phase clinical trials using autologous bone marrow cells, meaning cells harvested from the patient’s own bone marrow, have produced encouraging initial results.⁸ But these trials are small, and the field is far from settled on which cell type works best, what dose to use, or how many injections are needed. Stem cell therapy for ED is not yet available as a standard treatment, and any clinic marketing it as a proven cure is getting ahead of the science.

Platelet-rich plasma, or PRP, is another regenerative approach that has generated interest. PRP is made by concentrating the growth-factor-rich portion of a patient’s own blood and injecting it into the target tissue. An animal study in aged rats with nerve degeneration found that PRP injections rejuvenated degenerating nerve fibers, preserved the lining of penile blood vessels, and enhanced the process of nerve remyelination, which is how nerves rebuild their insulating sheath after damage.⁹ Human data specifically for post-prostatectomy patients remains thin, and PRP should be considered experimental at this stage.

Nerve Grafting and Intraoperative Monitoring

For men whose cavernous nerves could not be fully spared during surgery, a newer approach attempts to bridge the gap with a nerve graft. A Phase I clinical trial has tested a technique called somatic-autonomic nerve grafting, where a healthy nerve is used to reconnect the damaged pathway. Early results are genuinely intriguing: among patients followed for more than two months after the grafting procedure, average erectile function scores reached levels consistent with mild-to-moderate dysfunction, and some patients had already achieved penetrative intercourse.¹⁰ This is a small pilot study and far too early to draw broad conclusions, but the concept of surgically restoring the nerve circuit rather than relying on medications to compensate for its absence represents a genuinely different philosophy of treatment.

On the prevention side, intraoperative nerve monitoring aims to help surgeons do a better job of preserving the cavernous nerves during the original prostatectomy. By electrically stimulating tissue near the nerve during surgery and measuring the penile response, the surgeon gets real-time feedback on whether the nerve is intact. Early studies found that the vast majority of patients who showed a positive nerve response during surgery went on to recover erections afterward.¹¹ Other groups have confirmed that this monitoring technique is reliable and straightforward to perform.¹² It has not become universal, but its use is growing as robotic surgery platforms make it easier to integrate.

When Pills Do Not Work

For men whose ED does not respond to PDE5 inhibitors, which is common after non-nerve-sparing surgery, several established alternatives exist. Intracavernous injection therapy involves injecting a vasodilating drug directly into the side of the penis before sex. It bypasses the nerve pathway entirely and produces an erection through direct action on the blood vessels. Transurethral alprostadil, a small pellet inserted into the urethra, works through a similar mechanism with a less invasive delivery route. Both are effective for post-prostatectomy ED.¹³

Vacuum erection devices use negative pressure to draw blood into the penis, after which a constriction ring at the base maintains the erection. While they feel different from a natural erection and require some adjustment, they have an added benefit as a rehabilitation tool. Research in animal models of nerve injury has shown that regular vacuum device use helps preserve penile size and increases arterial blood flow to the tissue.¹⁴ Some rehabilitation protocols combine vacuum therapy with low-dose PDE5 inhibitors, aiming to keep the tissue oxygenated and stretch the smooth muscle while natural nerve recovery takes its course.¹⁵

Penile Implants as a Definitive Option

When all other approaches have been tried and the situation has not improved, inflatable penile prostheses remain what urologists sometimes call the “gold standard” for refractory ED.¹⁶ These are surgically implanted devices consisting of inflatable cylinders inside the penis, a fluid reservoir in the abdomen, and a small pump placed in the scrotum. When you want an erection, you squeeze the pump; when you are done, you press a release valve. Modern devices feel and look relatively natural, and satisfaction rates among men and their partners tend to be high.

Implant surgery is typically recommended only after other options have been exhausted, partly because the procedure permanently alters the penile tissue, making it difficult to rely on natural erections afterward even if nerve function were to improve.¹⁷ That said, for men who have waited years without meaningful recovery, the reliability of an implant can be genuinely life-changing. The timing of implant placement after prostatectomy is a conversation worth having early with your surgeon, even if you hope to recover function without one.

Pelvic Floor Training

Pelvic floor muscle training is mostly known for its role in recovering urinary continence after prostatectomy, but there is growing evidence that it contributes to erectile recovery as well. The pelvic floor muscles provide structural support for erections by compressing the base of the penis and helping trap blood inside the erectile tissue. After surgery, these muscles often weaken, and targeted exercises can help restore their function.

A systematic review of randomized controlled trials found that biofeedback-assisted pelvic floor training was associated with substantially higher potency rates at twelve months compared to no structured training. One included trial reported a potency rate of about 47% in the training group versus roughly 13% in controls. For men with persistent ED who began supervised training later, at twelve months post-surgery, there were still modest improvements in erectile function scores.¹⁸ Another randomized trial noted that while pelvic floor training did not produce immediate improvements in sexual function, it caused no harm and aligned well with the natural timeline of tissue recovery, making it a reasonable addition to a broader rehabilitation program.¹⁹

The appeal of pelvic floor work is that it is free, has no side effects, and can be done alongside every other treatment on this list. It is not a standalone cure, but dismissing it as irrelevant to erections would be a mistake.

The Partner Side of Recovery

One dimension of this problem that rarely gets enough attention is what happens to the couple, not just the individual. A study tracking couples through the prostatectomy process found that three months after surgery, 95% of men had some degree of ED, even though 75% still had partial tumescence. About 60% of couples were sexually active at that point. Notably, female partners’ sexual function, which was already in the range researchers classify as dysfunction before the surgery, declined further afterward.²⁰

This finding matters because ED treatment after prostatectomy tends to focus entirely on the man’s anatomy, while sexual intimacy is a shared experience that depends on both partners’ physical and emotional state. Couples counseling, sexual therapy, and honest communication about expectations are not soft add-ons to medical treatment. They are practical components that influence whether a restored erection actually translates to a restored sex life. A man who recovers firm erections but whose partner has developed anxiety around sex, or whose relationship has been strained by months of avoidance, may find that the medical fix alone does not produce the outcome he hoped for.

Predicting Your Odds Before Surgery

Not every man starts from the same baseline, and knowing your individual likelihood of recovery can shape realistic expectations and help you plan a rehabilitation strategy. Researchers have developed a preoperative risk stratification tool based on three factors available before surgery: age, the quality of erections before the operation, and overall health profile. This tool estimates the probability of erectile function recovery after bilateral nerve-sparing surgery and can help guide conversations about how aggressive to be with early rehabilitation.²¹

Younger men with strong erections and few other health problems before surgery have the best chance of recovering natural function. Men over 65, those with diabetes or cardiovascular disease, or those whose erections were already weakening before the diagnosis face longer odds with conservative approaches and may benefit from discussing implant surgery earlier rather than spending years on treatments that are less likely to work for them. The worst outcome is often not choosing the “wrong” treatment but waiting too long in a holding pattern while penile tissue deteriorates.